ArticlePharmaceuticals (Basel, Switzerland)2026
In Vitro Radiobiological Evaluation of [
Francesca Porto, Silvia Pasquini, Chiara Contri, Martina Cappello, Giorgia Speltri, Alessandra Boschi, Licia Uccelli, Rebecca Napolitano, Lorenza Marvelli, Katia Varani and 3 more
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Francesca PortoDepartment of Translational Medicine, University of Ferrara, Via L. Borsari, 46, 44121 Ferrara, Italy.
Silvia PasquiniDepartment of Translational Medicine, University of Ferrara, Via L. Borsari, 46, 44121 Ferrara, Italy.ORCID 0000-0001-9442-1428 Chiara ContriDepartment of Translational Medicine, University of Ferrara, Via L. Borsari, 46, 44121 Ferrara, Italy.ORCID 0000-0003-3936-5923 Martina CappelloDepartment of Translational Medicine, University of Ferrara, Via L. Borsari, 46, 44121 Ferrara, Italy.
Giorgia SpeltriDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via L. Borsari, 46, 44121 Ferrara, Italy.ORCID 0009-0008-4614-2772 Alessandra BoschiDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via L. Borsari, 46, 44121 Ferrara, Italy.ORCID 0000-0002-6382-1944 Licia UccelliDepartment of Translational Medicine, University of Ferrara, Via L. Borsari, 46, 44121 Ferrara, Italy.ORCID 0000-0002-1490-0718 Rebecca NapolitanoDepartment of Translational Medicine, University of Ferrara, Via L. Borsari, 46, 44121 Ferrara, Italy.
Lorenza MarvelliDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Via L. Borsari, 46, 44121 Ferrara, Italy.
Katia VaraniDepartment of Translational Medicine, University of Ferrara, Via L. Borsari, 46, 44121 Ferrara, Italy.ORCID 0000-0003-4562-1348 Giovanni Di DomenicoDepartment of Physics and Earth Sciences, University of Ferrara, Via Saragat, 1, 44122 Ferrara, Italy.
Petra MartiniDepartment of Environmental and Prevention Sciences, University of Ferrara, Via L. Borsari, 46, 44121 Ferrara, Italy.ORCID 0000-0002-4059-4814 Fabrizio VincenziDepartment of Translational Medicine, University of Ferrara, Via L. Borsari, 46, 44121 Ferrara, Italy.ORCID 0000-0002-5027-1699 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
[64Cu]CuCl2cell dosimetryperitoneal carcinomatosistheranostic agent
Identifiers
PMID42515716
PMCPMC13415221
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390